Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) closed the day trading at $141.57 up 0.28% from the previous closing price of $141.18. In other words, the price has increased by $0.28 from its previous closing price. On the day, 1.47 million shares were traded. NBIX stock price reached its highest trading level at $144.27 during the session, while it also had its lowest trading level at $138.49.
Ratios:
For a better understanding of NBIX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.77 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.19. For the most recent quarter (mrq), Quick Ratio is recorded 2.47 and its Current Ratio is at 2.52. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on April 24, 2024, Upgraded its rating to Overweight and sets its target price to $170 from $140 previously.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $136.Deutsche Bank initiated its Buy rating on December 12, 2023, with a $136 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 16 ’24 when Lippoldt Darin sold 7,004 shares for $150.00 per share. The transaction valued at 1,050,590 led to the insider holds 39,740 shares of the business.
Delaet Ingrid sold 2,857 shares of NBIX for $428,627 on Jul 16 ’24. The Chief Regulatory Officer now owns 6,607 shares after completing the transaction at $150.03 per share. On Jul 16 ’24, another insider, LYONS GARY A, who serves as the Director of the company, sold 930 shares for $150.03 each. As a result, the insider received 139,530 and left with 119,047 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NBIX now has a Market Capitalization of 14247181312 and an Enterprise Value of 13408063488. As of this moment, Neurocrine’s Price-to-Earnings (P/E) ratio for their current fiscal year is 38.92, and their Forward P/E ratio for the next fiscal year is 20.74. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.16. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.19 while its Price-to-Book (P/B) ratio in mrq is 5.97. Its current Enterprise Value per Revenue stands at 6.765 whereas that against EBITDA is 27.202.
Stock Price History:
Over the past 52 weeks, NBIX has reached a high of $150.39, while it has fallen to a 52-week low of $99.98. The 50-Day Moving Average of the stock is 1.43%, while the 200-Day Moving Average is calculated to be 7.47%.
Shares Statistics:
Over the past 3-months, NBIX traded about 767.48K shares per day on average, while over the past 10 days, NBIX traded about 787460 shares per day. A total of 98.70M shares are outstanding, with a floating share count of 98.41M. Insiders hold about 2.21% of the company’s shares, while institutions hold 92.82% stake in the company. Shares short for NBIX as of 1721001600 were 2625574 with a Short Ratio of 3.42, compared to 1718323200 on 2231985. Therefore, it implies a Short% of Shares Outstanding of 2625574 and a Short% of Float of 3.06.
